<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>chemoembolization combination therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chemoembolization-combination-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 26 Aug 2025 16:37:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>chemoembolization combination therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cell-Based Vaccine Enhances Liver Cancer Therapy, Slowing Disease Progression in Patients</title>
		<link>https://bioengineer.org/cell-based-vaccine-enhances-liver-cancer-therapy-slowing-disease-progression-in-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 26 Aug 2025 16:37:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[chemoembolization combination therapy]]></category>
		<category><![CDATA[dendritic cell vaccine clinical trial]]></category>
		<category><![CDATA[hepatocellular carcinoma immunotherapy]]></category>
		<category><![CDATA[liver cancer progression delay]]></category>
		<category><![CDATA[personalized cancer immunotherapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cell-based-vaccine-enhances-liver-cancer-therapy-slowing-disease-progression-in-patients/</guid>

					<description><![CDATA[In a groundbreaking advancement for liver cancer treatment, researchers from the University of Birmingham have demonstrated that a novel dendritic cell (DC) vaccine, when combined with established chemoembolization therapy, significantly extends the time patients remain free from tumor progression. This pioneering study, funded by the National Institute for Health and Care Research (NIHR) and published [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">258120</post-id>	</item>
	</channel>
</rss>
